Jove
Visualize
Contact Us

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Model Ensembling and Machine Learning Approaches to Predict the First Dose of Amoxicillin in Intensive Care.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy.

Antimicrobial agents and chemotherapy·2026
Same author

Preemptive Pharmacogenetics in Renal Transplantation: A Real-World Assessment of Pharmacogenetic Actionability.

Therapeutic drug monitoring·2026
Same author

Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing.

The Journal of antimicrobial chemotherapy·2026
Same author

Raltegravir Plasma Exposure: A Machine Learning-Based Model for its Prediction Using Limited Sampling Strategy.

The AAPS journal·2026
Same author

Challenges in early detection and prognostication of sepsis: new approaches from the emergency department and intensive care unit.

EClinicalMedicine·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 13, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

Daptomycin Dosage Optimization in Renal Impairment Using Model-Informed Precision Dosing.

Hamza Sayadi1, Yeleen Fromage1, Marc Labriffe1,2

  • 1Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.

Therapeutic Drug Monitoring
|September 12, 2024
PubMed
Summary

This case study highlights optimizing daptomycin dosing for patients with severe renal impairment to avoid toxicity and ensure treatment efficacy against MRSA infections. Adjusting dosage based on therapeutic drug monitoring is crucial.

Keywords:
Bayesian estimationdaptomycinefficacypopulation pharmacokineticstoxicity

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

521
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.5K

Related Experiment Videos

Last Updated: Jun 13, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

521
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.5K

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Daptomycin exposure impacts efficacy and toxicity, with individual variability.
  • A patient with severe renal impairment (eGFR 12 mL/min/1.73 m²) received daptomycin for MRSA infective endocarditis.
  • Standard dosing guidelines lack explicit recommendations for daptomycin in patients with eGFR < 30 mL/min/1.73 m².

Purpose of the Study:

  • To optimize daptomycin dosage in a patient with severe renal impairment.
  • To ensure therapeutic drug exposure while minimizing toxicity risks.
  • To manage MRSA infective endocarditis effectively in a renally impaired patient.

Main Methods:

  • Utilized a population pharmacokinetic model for Bayesian parameter estimation.
  • Calculated the 24-hour area under the curve (AUC24) using peak and trough plasma samples.
  • Adjusted daptomycin dosage iteratively based on AUC24/MIC ratios and toxicity thresholds.

Main Results:

  • Initial daptomycin AUC24 was 1091 h·mg/L, exceeding the target range for toxicity.
  • Dosage reductions to 700 mg and then 500 mg every other day were implemented.
  • The final adjusted dose achieved an AUC24 of 750 h·mg/L, within the desired therapeutic range.

Conclusions:

  • Successful treatment of MRSA infective endocarditis was achieved with adjusted daptomycin dosing.
  • The case emphasizes the importance of therapeutic drug monitoring in renally impaired patients.
  • A multidisciplinary approach is essential for individualized daptomycin dose adjustments.